Prevalence of Iron Deficiency in acute heart Failure

Completed

• Conditions: Failure of te heart function; Heart failure; 10019280

• Registration Number: NL-OMON50256
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1000

Inclusion Criteria

Hospitalisation due to acute heart failure

Exclusion Criteria

- History of erythropoietin stimulating agent, IV iron therapy, and/or blood
transfusion in previous 3 months prior to hospitalisation.
- Oral iron therapy at any dose and/or continious use of iron containing
multivitamines in previous 4 weeks prior to hospitalisation.
- History of receiving systemic chemotherapy and/or radiotherapy in previous 3
months prior to hospitalisation.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Prevalence of iron deficiency according to the definition of the ESC guidelines</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Associations between type and measures of severity of heart failure and iron<br /><br>deficiency;<br /><br>- Time course of measures of iron (deficiency), heart failure and<br /><br>co-morbidities</p><br>